Evolution designed us to die fast; we can change that — Jacob Kimmel

The event examines the evolutionary constraints on human longevity and the application of epigenetic reprogramming to reverse aging by utilizing Yamanaka factors and AI-driven discovery to optimize transcription factor combinations. It further details the transition from current delivery limitations to a future vision where engineered living cells patrol the body, alongside a strategic analysis of the biopharma sector's shifting reimbursement models and the critical need for general-purpose "virtual cell" platforms to overcome diminishing returns in drug discovery.